Mario Cazzola
Mario Cazzola
Professor of Hematology, University of Pavia
Verified email at unipv.it
Title
Cited by
Cited by
Year
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ...
Blood 127 (20), 2391-2405, 2016
54372016
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ...
New England Journal of Medicine 352 (17), 1779-1790, 2005
39052005
Revised international prognostic scoring system for myelodysplastic syndromes
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F SolÚ, ...
Blood 120 (12), 2454-2465, 2012
21392012
Somatic mutations of calreticulin in myeloproliferative neoplasms
KR Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi
New England Journal of Medicine 369 (25), 2379-2390, 2013
17502013
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood 122 (22), 3616-3627, 2013
13182013
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
11332007
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
11012011
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
10612013
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi, R Marchioli, J Kutti, H Gisslinger, G Tognoni, C Patrono, ...
New England Journal of Medicine 350 (2), 114-124, 2004
10392004
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
9982005
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research andá…
F Passamonti, F Cervantes, AM Vannucchi, E Morra, E Rumi, A Pereira, ...
Blood 115 (9), 1703-1708, 2010
7612010
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
N Engl J Med 368, 22-33, 2013
6562013
Mutations and prognosis in primary myelofibrosis
AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ...
Leukemia 27 (9), 1861-1869, 2013
6012013
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellstr÷m-Lindberg, D Bowen, L Ades, J Cermak, ...
Blood 122 (17), 2943-2964, 2013
5662013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
E Rumi, D Pietra, V Ferretti, T Klampfl, AS Harutyunyan, JD Milosevic, ...
Blood 123 (10), 1544-1551, 2014
5542014
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti, E Rumi, E Pungolino, L Malabarba, P Bertazzoni, ...
The American journal of medicine 117 (10), 755-761, 2004
5252004
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874-1881, 2013
5232013
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011
4562011
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, G Mufti, ...
Blood 118 (14), 3765-3776, 2011
4272011
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
S Stilgenbauer, A Schnaiter, P Paschka, T Zenz, M Rossi, K D÷hner, ...
Blood 123 (21), 3247-3254, 2014
4262014
The system can't perform the operation now. Try again later.
Articles 1–20